Subscribe to KPMG's Deal Capsule Life Sciences Newsletter

Preview of the KPMG Deal Capsule Life Sciences Newsletter

The new edition of our quarterly newsletter on transactions in the global life sciences industry glances back at the significant deals that took place in Q1-Q3 2021.

Life Sciences M&A activity continues its steady trend, already exceeding in Q3 2021 the previous full-year levels.

  • Continuous momentum in biotech and medical devices & diagnostics subsectors drove life sciences M&A activity in Q1-Q3 2021.
  • Focus of M&A activities was primarily on nutrition and healthcare, digitalization, robotic surgeries and novel therapeutics.

Register here:

Connect with us

Stay up to date with what matters to you

Gain access to personalized content based on your interests by signing up today

Sign up today